Abstract
This article is concerned mainly with recurrent ulceration (RU) after vagotomy [truncal (TV), selective (SV), or highly selective (HSV)]. RU may be symptomatic or asymptomatic. Since few surgeons routinely perform endoscopy on asymptomatic patients, it is symptomatic RU that is being discussed.
After all 3 types of vagotomy, without antrectomy, median incidences of RU are about 10% after 5–10 years, but there is wide variation, from 1% to 30%. There is no convincing evidence that TV denervates the parietal cell mass more effectively than does SV or HSV, or that it has a lower incidence of RU than SV or HSV. Claims that SV and HSV lead to fewer incomplete vagotomies and less RU than TV are, however, not convincing. Since SV + P (pyloroplasty) or gastrojejunostomy (GJ) carries the same risk of RU as HSV, but has more side effects because of loss of the pylorus, it has been abandoned. The choice of elective operation for duodenal ulcer (DU) thus lies among TV + D (truncal vagotomy + drainage procedure), HSV, and V + A (vagotomy + antrectomy).
The results of 5 controlled trials suggest that HSV yields better overall clinical results than V + A, even though the incidence of RU is 1% after V + A compared with 10% after HSV. Even for patients with hypersecretion of acid, V + A should not be employed in preference to HSV, because incidences of RU after HSV are no higher among hypersecretors of acid than among normal secretors. Gastrin cell (G-cell) hyperplasia and “antral dominance” are concepts still too nebulous to influence the choice of elective operation for DU.
After complete vagotomy (TV, SV, or HSV), as shown by the Burge, Grassi, or Hollander tests, the incidence of RU is 2–5%. High incidences of RU are not related to any characteristic of the patient, the level of acid output, or the ulcer, but are related to the surgeon who operates. They are thus related to operative technique, and are preventable.
Despite the advent of H 2-receptor antagonists, elective vagotomy (preferably in the form of HSV) still has a place in the management of DU because it is more effective than H 2-blockers in lowering intragastric acidity permanently and in preventing recurrent ulceration.
Résumé
Cet article est consacré principalement à la récidive ulcéreuse (RU) après vagotomie [tronculaire (VT), vagotomie sélective (VS), vagotomie hautement sélective (VHS)]. La récidive ulcéreuse peut Être symptomatique ou asymptomatique. En raison du fait que peu de chirurgiens pratiquent systématiquement l'exploration endoscopique, c'est la récidive ulcéreuse symptomatique qui a été prise en considération.
Après les 3 variétés de vagotomie, sans antrectomie, la fréquence moyenne de récidive ulcéreuse après 5 ans est d'environ 10% avec une large variation allant de 1% à 30%. Aucun fait convaincant ne démontre que la VT dénerve plus efficacement la masse cellulaire pariétale que la VS ou la VHS et que la récidive ulcéreuse est alors moindre. Cependant les affirmations selon lesquelles la VS et la VHS aboutissent à un taux plus bas de vagotomies incomplètes et un taux plus bas de récidives ulcéreuses, ne sont pas convaicantes. Par ailleurs, du fait que la VS associée à une pyloroplastie ou à une gastrojéjunostomie comporte le mÊme risque de récidive que la VHS mais qu'elle présente en outre des effets secondaires nocifs consécutifs à la perte de la fonction pylorique, cette méthode a été abandonnée.
Plusieurs groupes contrôlés de résultats à 5 ans suggèrent que la VHS donne au total de meilleurs résultats cliniques que la vagotomie associée à l'antrectomie et ceci en dépit du fait que le taux de récidive est de 1% après V + A alors qu'il est de 10% après VHS. MÊme chez les malades qui présentent une hypersécrétion acide la V + A ne doit pas Être utilisée de préférence à la VHS car la fréquence de la récidive ulcéreuse après la VHS n'est pas plus élevée chez les malades hypersécrétants que chez les sujets dont la sécrétion est normale. L'hyperplasie des cellules G et la dominante antrale sont des concepts encore trop incertains pour qu'il soient pris en considération dans le choix de l'intervention.
Après vagotomie complète (VT, VS, ou VHS) démontrée par les tests de Burge, de Grassi, ou de Hollander, la fréquence de la récidive ulcéreuse est de 2 à 5%. Le taux élevé de récidive ulcéreuse n'est pas le fait de facteurs inhérents au malade, au débit acide ou à l'ulcère; il correspond en réalité aux qualités du chirurgien, en un mot il dépend de la qualité de la technique opératoire. Il est donc possible de prévenir la RU.
Malgré l'avènement des anti-H2 la VS (la VHS en particulier) garde une place dans le traitement de l'ulcère duodénal car elle est plus efficace que ces agents du fait qu'elle abaisse en permanence l'acidité intra-gastrique et prévient ainsi la récidive de l'ulcère.
Resumen
Este artículo se refiere principalmente a la ulceratión recurrente (UR) después de vagotomía [troncular (VT), selectiva (VS), o altamente selectiva (VAS)]. La UR puede ser sintomática o asintomática. Puesto que muy pocos cirujanos realizan endoscopia rutinaria de pacientes asintomáticos, la discusión se limita a la UR sintomática.
Después de los 3 tipos de vagotomía, sin antrectomía, la incidencia promedio de UR es de alrededor de 10% a los 5–10 años, pero se observa una gran variación, con tasas de 1% a 30%. No existe evidencia de que la VT logre la denervación de la masa celular parietal en forma más efectiva de lo que lo hace la VS o la VAS, ni de que exhiba una menor incidencia de UR. Además, las pretensiones de que la VS o la VAS se acompañan de menores tasas de vagotomía incompleta y menos UR que la VT, no son tampoco convincentes. Puesto que la VS + P o GY implica el mismo riesgo de UR que la VAS pero tiene más efectos colaterales debido a la péridida del píloro, ha sido abandonada. La escogencia de una operación electiva para UD se halla entre VT + D (drenaje), VAS, y V + A (antrectomía).
Los resultados de 5 estudios controlados sugieren que la VAS produce mejores resultados clínicos globales que la V + A, aunque la incidencia de UR es de 1% después de V + A en comparación con 10% después de VAS. Aun en pacientes con hipersecreción de ácido, la V + A no debe ser empleada en preferencia sobre la VAS puesto que las tasas de UR después de VAS no son mayores en los hipersecretores de ácido que en los normosecretores. La hiperplasia de células G y la “dominancia antral” son conceptos todavía muy nebulosos para que puedan influenciar la escogencia de la operación electiva para UD.
Después de una vagotomía completa (VT, VS, o VAS), demostrado por las pruebas de Burge, Grassi, o de Hollander, la incidencia de UR es de 2–5%. Las altas incidencias de UR no se relacionan con característica alguna del paciente, con la producción de ácido o con su Úlcera, sino con el cirujano que realiza la operación. Se correlacionan con la técnica operatoria y, por lo tanto, son previsibles.
A pesar del advenimiento de los antagonistas de receptores H2, la vagotomía electiva (preferencialmente en forma de VAS) todavía posée un lugar en el manejo de UD, porque es más efectiva que los bloqueadores H2 en la reducción permanente de la acidez intragástrica y en la prevención de ulceración recurrente.
Similar content being viewed by others
References
Muhe, E., Muller, C., Martinoli, S., Schacht, U., Fiedler, L., Engelke, B., Zumtobel, V., Marrie, A.: Five-years' results of a prospective multicentre trial of proximal gastric vagotomy. In Vagotomy in Modern Surgical Practice, J.H. Baron, J. Alexander-Williams, M. Allgöwer, C. Muller, J. Spencer, editors, London, Butterworths, 1982, pp. 176–186
Muller, C.: Recurrent peptic ulcer after proximal gastric vagotomy. In Vagotomy in Modern Surgical Practice, J.H. Baron, J. Alexander-Williams, M. Allgöwer, C. Muller, J. Spencer, editors, London, Butterworths, 1982, pp. 312–318
Goligher, J.C., Pulvertaft, C.N., DeDombal, F.T., Conyers, J.H., Duthie, H.L., Feather, D.B., Latchmore, A.J.C., Shoesmith, J.H., Smiddy, F.G., Willson-Pepper, J.: Five- to eight-year results of Leeds/York controlled trial of elective surgery for duodenal ulcer. Br. Med. J.2:781, 1968
Postlethwait, R.W.: Five-year follow-up results of operations for duodenal ulcer. Surg. Gynecol. Obstet.131:387, 1973
Herrington, J.L.: Truncal vagotomy with antrectomy. Surg. Clin. North Am.56:1335, 1976
Stabile, B.E., Passaro, E.: Recurrent peptic ulcer. Gastroenterology70:124, 1976
Cleator, I.G.M., Holubitsky, I.B., Harrison, R.C.: Anastomotic ulceration. Ann. Surg.179:339, 1974
Johnston, D.: A therapeutic index (scoring system) for the evaluation of operations for peptic ulcer. Gastroenterology70:433, 1976
Johnston, D., Goligher, J.C.: The influence of the individual surgeon and of the type of vagotomy upon the insulin test after vagotomy. Gut12:963, 1971
Adami, H.-O., Enander, L.-K., Enskog, L., Ingvar, C., Rydberg, B.: Recurrences 1 to 10 years after highly selective vagotomy in prepyloric and duodenal ulcer disease. Ann. Surg.199:393, 1984
Kennedy, T., Connell, A.M.: Selective or truncal vagotomy? Lancet1:899, 1969
Kennedy, T., Connell, A.M., Love, A.H.G., MacRae, K.D., Spencer, E.F.A.: Selective or truncal vagotomy: Five-year results of a double-blind prospective, randomised, controlled trial. Br. J. Surg.60:944, 1973
Sawyers, J.L., Scott, H.W., Edwards, W.H., Shull, H.J., Law, D.H.: Comparative studies of the clinical effects of truncal and selective gastric vagotomy. Am. J. Surg.115:165, 1968
Kronborg, O., Malmstrom, J., Christiansen, P.M.: A comparison between the results of truncal and selective vagotomy in patients with duodenal ulcer. Scand. J. Gastroenterol.5:519, 1970
De Miguel, J.: Selective gastric vagotomy and drainage, and highly selective vagotomy for duodenal ulcer. Comparative long-term results. In Vagotomy in Modern Surgical Practice, J.H. Baron, J. Alexander-Williams, M. Allgöwer, C. Muller, J. Spencer, editors, London, Butterworths, 1982, pp. 155–158
Muller, C., Martinoli, S., Allgöwer, M.: The vagomotor electrotest (modified Burge test) for completeness of vagotomy. In Vagotomy in Modern Surgical Practice, J.H. Baron, J. Alexander-Williams, M. Allgöwer, C. Muller, J. Spencer, editors, London, Butterworths, 1982, pp. 77–85
Mackay, C.: Recurrent ulcer: Incidence and complications. In Vagotomy in Modern Surgical Practice, J.H. Baron, J. Alexander-Williams, M. Allgöwer, C. Muller, J. Spencer, editors, London, Butterworths, 1982, pp. 306–310
Kronborg, O., Madsen, P.: A controlled, randomized trial of highly selective vagotomy versus selective vagotomy and pyloroplasty in the treatment of duodenal ulcer. Gut16:268, 1975
Andersen, S., Høtrup, H., Amdrup, E.: The Aarhus County Vagotomy Trial II. An interim report on reduction in acid secretion and ulcer recurrence rate following parietal cell vagotomy and selective gastric vagotomy. World J. Surg.2:91, 1978
Sawyers, J.L., Herrington, J.L., Burney, D.P.: Proximal gastric vagotomy compared with vagotomy and antrectomy and selective gastric vagotomy and pyloroplasty. Ann. Surg.186:510, 1977
Fraser, A.G., Brunt, P.W., Matheson, N.A.: A comparison of highly selective vagotomy with truncal vagotomy and pyloroplasty-one surgeon's results after 5 years. Br. J. Surg.70:485, 1983
Stoddard, C.J., Johnson, A.G., Duthie, H.L.: The four to eight year results of the Sheffield trial of elective duodenal ulcer surgery-highly selective or truncal vagotomy? Br. J. Surg.71:779, 1984
Koffman, C.G., Hay, D.J., Ganguli, P.G., Elder, J.B., Gillespie, I.E., Mantoudis, S.M., Tweedle, D.E.F., Schofield, P.F., Palmer, M.: A prospective randomized trial of vagotomy in chronic duodenal ulceration: 4-year follow-up. Br. J. Surg.70:342, 1983
Wastell, C., Colin, J., Wilson, T., Walker, E., Gleeson, J., Zeegan, R.: Prospectively randomized trial of proximal gastric vagotomy either with or without pyloroplasty in treatment of uncomplicated duodenal ulcer. Br. Med. J.2:851, 1977
Clark, C.G., Fresini, A., Aranjo, T.G., Boulos, P.B.: Proximal gastric vagotomy or truncal vagotomy and drainage for chronic duodenal ulcer? Br. J. Surg.73:298, 1986
Dorricott, N.J., McNeish, A.R., Alexander-Williams, J., Royston, C.M.S., Cooke, W.M., Spencer, J., De Vries, B.C., Muller, H.: Prospective randomised multicentre trial of proximal gastric vagotomy or truncal vagotomy and antrectomy for chronic duodenal ulcer: Interim results. Br. J. Surg.65:152, 1978
De Vries, B.C., Schattenkerk, M.E., Smith, E.E.J., Spencer, J., Jackson, D.S., Alexander-Williams, J., Dorricott, N.J.: Prospective randomized multicentre trial of proximal gastric vagotomy or truncal vagotomy and antrectomy for chronic duodenal ulcer: Results after 5–7 years. Br. J. Surg.70:701, 1983
Jordan, P.H., Jr.: A prospective study of parietal cell vagotomy and selective vagotomy-antrectomy for treatment of duodenal ulcer. Ann. Surg.183:619, 1976
Jordan, P.H., Jr.: An interim report on parietal cell vagotomy versus selective vagotomy and antrectomy for treatment of duodenal ulcer. Ann. Surg.189:643, 1979
Gleysteen, J.J., Condon, R.E., Tapper, E.J.: Prospective trial of proximal gastric vagotomy. Surgery94:15, 1983
Koo, J., Lim, S.K., Chan, P., Lee, N.W., Lam, P., Wong, J., Ong, G.B.: Proximal gastric vagotomy, truncal vagotomy with drainage and truncal vagotomy with antrectomy for chronic duodenal ulcer. Ann. Surg.197:265, 1983
Johnston, D.: Surgery for duodenal ulceration in 1984: Highly selective vagotomy with intact pylorus or vagotomy with antrectomy? Internal Medicine for the Specialist5:55, 1984
Gillespie, I.E., Kay, A.W.: Effect of medical and surgical vagotomy on the augmented histamine test in man. Br. Med. J.1:1557, 1961
Hansky, J.: Hypergastrinaemia, hyperacidity and peptic ulceration. Rendiconti di Gastroenterologica9:61, 1977
Wormsley, K.G., Grossman, M.I.: Maximal histalog test of gastric secretion in control subjects and patients with peptic ulcer. Gut6:427, 1965
Baron, J.H.: Clinical tests of Gastric Secretion-History, Methodology and Interpretation, London, The Macmillan Press, 1978, pp. 8–12
Kronborg, O.: The discriminatory ability of gastric acid secretion tests in the diagnosis of recurrence after truncal vagotomy and drainage for duodenal ulcer. Scand. J. Gastroenterol.8:483, 1973
Kronborg, O.: Gastric acid secretion and risk of recurrence of duodenal ulcer within six to eight years after truncal vagotomy and drainage. Gut15:714, 1974
Madsen, P., Kronborg, O.: Recurrent ulcer 5 1/2–8 years after highly selective vagotomy without drainage and selective vagotomy with pyloroplasty. Scand. J. Gastroenterol.15:193, 1980
Aadland, E., Berstad, A., Semb, L.S., Bjerle, K.: Effect of cimetidine on pentagastrin-stimulated gastric secretion before and after proximal gastric vagotomy for duodenal ulcer. Scand. J. Gastroenterol.13:679, 1978
Gledhill, T., Buck, M., Paul, A., Hunt, R.H.: Cimetidine or vagotomy. Comparison of the effects of proximal gastric vagotomy, cimetidine and placebo on nocturnal intragastric acidity and acid secretion in patients with cimetidine resistant duodenal ulcer. Br. J. Surg.70:704, 1983
Hunt, R.H., Vincent, D., Kelly, J.M., Perry, M., Milton-Thompson, G.J.: Comparison of medical and surgical reduction in intragastric acidity in duodenal ulcer. Gut21:A455, 1980
Gear, M.W.L.: Proximal gastric vagotomy versus long-term maintenance treatment with cimetidine for chronic duodenal ulcer. Br. Med. J.1:286, 1983
Fawcett, A.N., Johnston, D., Duthie, H.L.: Revagotomy for recurrent ulcer after vagotomy and drainage for duodenal ulcer. Br. J. Surg.65:111, 1969
Aeberhard, P., Walther, M.: Results of a controlled randomized trial of proximal gastric vagotomy with and without pyloroplasty. Br. J. Surg.65:634, 1978
Moreno Gonzales, E., Narbona Arnau, B., Charlo Dupont, T., Figueroa Andollo, J.: Proximal gastric vagotomy: A prospective study of 829 patients with 4-year follow-up. Acta Chir. Scand.149:69, 1983
Hallenbeck, G.A., Gleysteen, J.J., Aldrete, J.S., Slaughter, R.L.: Proximal gastric vagotomy: Effects of two operative techniques on clinical and gastric secretory results. Ann. Surg.184:435, 1976
Boné, J., Høst, V., Brandsborg, O., Brandsborg, M., Mikkelsen, K., Amdrup, E.: An experimental study of parietal cell vagotomy with further graduated denervation of the antrum. World J. Surg.2:249, 1978
Johnson, A.G., Baxter, H.K.: Where is your vagotomy incomplete-observations on operative technique. Br. J. Surg.64:583, 1977
Johnson, A.G.: pH testing. In Vagotomy in Modern Surgical Practice, J.H. Baron, J. Alexander-Williams, M. Allgöwer, C. Muller, J. Spencer, editors, London, Butterworths, 1982, pp. 86–90
Rosati, I., Serantoni, C., Ciani, P.A.: Extended selective proximal vagotomy: Observations on a variant in technique. Chir. Gastroenterol.10:33, 1976
Burge, H., Vane, J.R.: Method of testing for complete nerve section during vagotomy. Br. Med. J.1:615, 1958
Grassi, G.: A new test for complete nerve section during vagotomy. Br. J. Surg.58:187, 1971
Hollander, F.: Laboratory procedures in the study of vagotomy (with particular reference to the insulin test). Gastroenterology11:419, 1948
Stenquist, B., Knutson, U., Olbe, L.: Gastric acid responses to adequate and modified sham feeding and to insulin hypoglycaemia in duodenal ulcer patients. Scand. J. Gastroenterol.13:357, 1978
Feldman, M., Richardson, C.T., Fordtran, J.S.: Experience with sham feeding as a test for vagotomy. Gastroenterology79:792, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnston, D., Blackett, R.L. Recurrent peptic ulcers. World J. Surg. 11, 274–282 (1987). https://doi.org/10.1007/BF01658103
Issue Date:
DOI: https://doi.org/10.1007/BF01658103